Clinical Trials Browser

Phase 1/2 × Unknown × Immunotherapy × Clear all

NCT03864211 2022-09-29

Thermal Ablation Followed by Immunotherapy for HCC

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular